Results 251 to 260 of about 87,925 (315)

A CASE OF GIST SUCCESSFULLY TREATED WITH IMATINIB MESILATE(STI571).

, 2003
T. Terada, Sadahito USUI, Hirohisa Kajiwara, Miwa Katagiri, Yoshinobu Sumiyama, Toshiaki OHARAZEKII   +5 more
openalex   +2 more sources

A patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib

Genetics in Medicine, 2017
Dinel Pond, Florence A. Arts, N. Mendelsohn, J. Demoulin, G. Scharer, Y. Messinger   +5 more
semanticscholar   +1 more source

Imatinib induced lichen planus

Indian Journal of Dermatology, 2011
S Anandan, R Sudha, K Krishnarathnam, TP Vetrichevvel   +3 more
openaire   +4 more sources

Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study. [PDF]

Blood Cancer J
Busque L, Beaudet MÉ, Harnois M, Moussa H, Szuber N, Mollica L, Delage R, Olney H, Laneuville P, Cournoyer G, Chamakhi I, Lalancette M, Talbot D, Ethier V, Desjardins P, Assouline S.   +15 more
europepmc   +1 more source

Low-dose Imatinib Efficacy in a Gastrointestinal Stromal Tumor Patient With KIT Exon 11 W557_K558 Deletion. [PDF]

In Vivo
Suto H, Kawamura M, Morita M, Sakai H, Onoe T, Ikeuchi K, Kajimoto K, Matsumoto K.   +7 more
europepmc   +1 more source

Irreversible Imatinib-induced Pneumonitis following Long-term Imatinib Administration

Internal Medicine, 2007
Tetsuya Mine, Takashi Seto, Kenji Eguchi, Nobuhiko Seki, Akemi Ito, Kennichi Watanabe, Kazutsugu Uematsu, Reishi Shibakuki   +7 more
openaire   +4 more sources

Therapeutic Challenges and Emerging Strategies for <i>T674I</i> and <i>PTPN11</i> Mutations in a <i>FIP1L1-PDGFRA</i>-Positive Myeloproliferative Neoplasm: A Case Report. [PDF]

Life (Basel)
Özkan SG, Kimiaei A, Safaei S, Karkucak M, Yenerel MN, Öztürkmen AY, Alp B, Özkan HA.   +7 more
europepmc   +1 more source

Standard Poster Abstracts for the 17th Asia Pacific Heart Rhythm Society (APHRS) Scientific Sessions

Journal of Arrhythmia, Volume 41, Issue 2, April 2025.
wiley   +1 more source

Unraveling a novel therapeutic facet of Etravirine to confront Hepatocellular Carcinoma via disruption of cell cycle. [PDF]

Sci Rep
Nair G, Saraswathy GR, Aranjani JM, Ibrahim R.   +3 more
europepmc   +1 more source

Design and fabrication of novel microfluidic-based droplets for drug screening on a chronic myeloid leukemia cell line. [PDF]

PLoS One
Jaafari N, Kojabad AA, Shabestari RM, Safa M.   +3 more
europepmc   +1 more source